To determine whether necroptosis is activated and contributes to the survival rates of CCA patients, phosphorylated MLKL (pMLKL) and RIPK1–RIPK3 interaction were developed to detect necroptosis activation in human primary tissues. Here, RIPK1 is linked to cholangiocarcinoma.